Conducting clinical trials and bringing products to market requires a huge amount of documentation. Pearl carries out collaborative review for various regulatory and clinical documents, including reports, investigator brochures, briefing documents and protocols.
- Cuts down on the number of review cycles with the ability to review changes in real-time
- Improves version control with access to documents in a controlled, collaborative environment
- Cuts down on conflicts and duplication by letting reviewers see and respond to each other
We have been able to almost eliminate the amount of time authors spend collating comments into the next version and are now far more efficient about resolution of conflicting reviewer comments. Our authors now spend more time focused on the development of document content rather than document formattingMatt Fitzpatrick, Manager Regulatory Affairs, Pearl Therapeutics, Inc.